These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7867530)

  • 21. [Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome].
    Ostuni P; Botsios C; Sfriso P; Bertagnin A; Cozzi F; Doria A; Todesco S
    Minerva Med; 2002 Jun; 93(3):203-9. PubMed ID: 12094151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological findings consistent with primary Sjögren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations.
    Sirois DA; Natelson B
    J Rheumatol; 2001 Jan; 28(1):126-31. PubMed ID: 11196514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjögren's syndrome.
    Márton K; Boros I; Varga G; Zelles T; Fejérdy P; Zeher M; Nagy G
    Oral Dis; 2006 Sep; 12(5):480-6. PubMed ID: 16910919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xerostomia following radiotherapy of the head and neck affects vocal function.
    Roh JL; Kim AY; Cho MJ
    J Clin Oncol; 2005 May; 23(13):3016-23. PubMed ID: 15860858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral manifestations in patients with Sjögren's syndrome.
    Soto-Rojas AE; Villa AR; Sifuentes-Osornio J; Alarcón-Segovia D; Kraus A
    J Rheumatol; 1998 May; 25(5):906-10. PubMed ID: 9598889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?
    Pers JO; d'Arbonneau F; Devauchelle-Pensec V; Saraux A; Pennec YL; Youinou P
    Arthritis Rheum; 2005 Aug; 52(8):2411-4. PubMed ID: 16052575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
    Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral candidiasis and Sjögren's syndrome.
    Soto-Rojas AE; Villa AR; Sifuentes-Osornio J; Alarcón-Segovia D; Kraus A
    J Rheumatol; 1998 May; 25(5):911-5. PubMed ID: 9598890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of the salivary and gastrointestinal systems. II. Effects of salivary gland dysfunction on the gastrointestinal tract.
    Valdez IH; Fox PC
    Dig Dis; 1991; 9(4):210-8. PubMed ID: 1914220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary gland parameters and clinical data related to the underlying disorder in patients with persisting xerostomia.
    van den Berg I; Pijpe J; Vissink A
    Eur J Oral Sci; 2007 Apr; 115(2):97-102. PubMed ID: 17451498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xerostomia and glossodynia in patients with autoimmune disorders.
    Rhodus NL
    Ear Nose Throat J; 1989 Oct; 68(10):791-4. PubMed ID: 2693062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral symptoms associated with fibromyalgia syndrome.
    Rhodus NL; Fricton J; Carlson P; Messner R
    J Rheumatol; 2003 Aug; 30(8):1841-5. PubMed ID: 12913944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjögren's syndrome.
    Turkcapar N; Sak SD; Saatci M; Duman M; Olmez U
    J Rheumatol; 2005 Jun; 32(6):1063-70. PubMed ID: 15940769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome.
    Walker J; Gordon T; Lester S; Downie-Doyle S; McEvoy D; Pile K; Waterman S; Rischmueller M
    J Rheumatol; 2003 Nov; 30(11):2406-12. PubMed ID: 14677185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xerostomia. Clinical aspects, pathology and pathogenesis.
    Bertram U
    Acta Odontol Scand; 1967; 25():Suppl 49:1-126. PubMed ID: 5299294
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.
    de Seze J; Dubucquoi S; Fauchais AL; Hachulla E; Matthias T; Lefranc D; Hatron PY; Vermersch P; Witte T
    J Rheumatol; 2004 Mar; 31(3):500-3. PubMed ID: 14994394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation, differential diagnosis, and treatment of xerostomia.
    Daniels TE
    J Rheumatol Suppl; 2000 Dec; 61():6-10. PubMed ID: 11128701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiety and depression in patients with primary Sjögren's syndrome.
    Valtýsdóttir ST; Gudbjörnsson B; Lindqvist U; Hällgren R; Hetta J
    J Rheumatol; 2000 Jan; 27(1):165-9. PubMed ID: 10648034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.